GSA Capital Partners’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-15,882
Closed -$268K 2066
2015
Q4
$268K Buy
15,882
+2,582
+19% +$43.8K 0.01% 1516
2015
Q3
$240K Buy
13,300
+4,400
+49% +$98K 0.01% 1491
2015
Q2
$230K Buy
+8,900
New +$225K 0.01% 1757

Other funds holding ENTL

GSA Capital Partners's ENTL Position: Q1 2016 in Review

GSA Capital Partners sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q1 2016, closing a stake of 15,882 shares — an estimated $268K sold.

GSA Capital Partners first reported a position in ENTL in Q2 2015 and held it in 3 quarters. The position peaked at $268K in Q4 2015. 56 funds tracked by Wall St. Rank hold ENTL as of Q1 2016.

  • GSA Capital Partners reported no remaining Entellus Medical, Inc. Common Stock position as of Q1 2016 after selling out during the quarter.
  • GSA Capital Partners sold 15,882 Entellus Medical, Inc. Common Stock shares in Q1 2016, an estimated $268K.
  • GSA Capital Partners first reported a position in Entellus Medical, Inc. Common Stock in Q2 2015 and held it in 3 quarters.
  • GSA Capital Partners's Entellus Medical, Inc. Common Stock position peaked at $268K in Q4 2015.
  • 56 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q1 2016.

Based on GSA Capital Partners's 13F filing for Q1 2016, filed 11 May 2016.